Finally, an additional important hint from this study is whether we should put efforts to develop new therapeutic strategies in HER2-low breast cancer patients, since pCR retained its favorable prognostic significance independently of HER2 expression levels. The gene discussed is ERBB2; the disease is breast cancer.